CHEMCATCHEM
COMMUNICATIONS
DOI: 10.1002/cctc.201402077
Identification and Application of Enantiocomplementary
Lactamases for Vince Lactam Derivatives
[
a, b]
[a]
[a]
[a]
[b]
Zeinab Assaf,
Elisabeth Eger, Zeljko Vitnik, Walter M. F. Fabian, Doris Ribitsch,
[b, c]
[a]
[a]
Georg M. Guebitz,
Kurt Faber, and Mꢀlanie Hall*
Four enzymes showing hydrolytic activity on derivatives of 2-
azabicyclo[2.2.1]hept-5-en-3-one (Vince lactam) were success-
fully identified through analysis of protein crystal structure and
amino acid sequence alignments. Enantiocomplementary activ-
ities were observed on Vince lactam and its saturated analog
Numerous chemical strategies have been developed for the
synthesis of enantiopure carbocyclic nucleosides, such as Mit-
[5]
sunobu and transition-metal-mediated reactions. The imple-
mentation of biocatalysis, in contrast, provides an attractive, ef-
ficient, and greener alternative. Chemoenzymatic processes
have therefore been developed on the basis of the kinetic res-
olution of racemic Vince lactam, which generates two enantio-
pure compounds of synthetic value (Schemes 1 and 2). Several
sources of enantiospecific enzymatic activities have been re-
ported: 1) (+)-g-Lactamase activities have been identified in
2-azabicyclo[2.2.1]heptan-3-one with non-heme chloroperoxi-
dase (CPO-T) from Streptomyces aureofaciens, cyclic imide hy-
drolase (CIH) from Pseudomonas putida, polyamidase (NfpolyA)
from Nocardia farcinica, and amidase (AMI) from Rhodococcus
globerulus, and perfect kinetic resolution was achieved (E>
[6]
200). Computational analysis of amide bond resonance stabili-
whole cells of Pseudomonas cepacia, Pseudomonas solanacea-
[7]
zation in lactams correlated well with the overall reactivity pat-
tern of the lactams as a function of ring size and strain. The
biocatalysts cloned and investigated in this study could be of
interest for the synthesis of enantiopure carbocyclic nucleoside
analogues.
rum (referred to as ENZA 20), and Pseudomonas fluorescens
[1c]
(ENZA 22). Related (+)-enantioselective enzymes have been
[8]
isolated from Sulfolobus solfataricus, Comamonas acidovor-
[9]
[10]
ans, and Bradyrhizobium japonicum and were cloned and
overexpressed in E. coli. 2) Microorganisms exhibiting (À)-g-lac-
[7]
tamase activity include Rhodococcus sp. (ENZA 1) and Aureo-
[1c]
bacterium sp. (ENZA 25). Analysis of the crystal structure of
(À)-g-lactamase isolated from Aureobacterium sp. attributed
the protein to the a/b-hydrolase fold family and supported
The bicyclic g-lactam 2-azabicyclo[2.2.1]hept-5-en-3-one (Vince
lactam, 1a) and derivatives thereof are versatile synthons that
have been exploited in enantiomerically pure form as precur-
sors for the preparation of carbocyclic nucleoside analogues
that possess therapeutic properties ranging from antibiotic ac-
[11]
a mechanism based on a Ser-His-Asp catalytic triad. Addi-
tionally, promiscuous lactamase activity on Vince lactam and
a few derivatives thereof (including 2-azabicyclo[2.2.1]heptan-
3-one, N-tert-butoxycarbonyl-protected and N-acetylated Vince
lactam) was identified in a range of commercially available hy-
[
1]
tivity to antitumor and antiviral activities. The (À)-enantiomer
of Vince lactam, for instance, was employed as a precursor in
the synthesis of purine carbonucleosides, including (À)-carbo-
[12]
drolytic enzymes (esterases, lipases, and proteases). Some of
these biocatalysts, regardless of their enantioselectivity, have
been characterized and protein structures are available. How-
ever, enantiocomplementary enzymes, applicable to the syn-
thesis of a broad set of Vince lactam derivatives that would
allow a more systematic use of biocatalysis in carbocyclic nu-
cleoside synthesis, are lacking. We therefore initiated a broad
search for potential new enzyme candidates, with focus on
Vince lactam derivatives so far not known to be substrates in
enzyme-catalyzed lactam hydrolysis. Non-heme cofactor-free
[
2,3]
vir and abacavir, both active against HIV.
The hydrolyzed
Vince lactam amino acid product (i.e., 1b) has also been used
as a starting material in the synthesis of pharmaceutical tar-
[
4]
gets, such as melogliptin and MK-0812 (Scheme 1).
[a] Dr. Z. Assaf, E. Eger, Dr. Z. Vitnik, Prof. Dr. W. M. F. Fabian, Prof. Dr. K. Faber,
Dr. M. Hall
Department of Chemistry
University of Graz
Heinrichstrasse 28, 8010 Graz (Austria)
E-mail: melanie.hall@uni-graz.at
[
13]
chloroperoxidase (CPO-T) from Streptomyces aureofaciens,
[14]
polyamidase (NfpolyA) from Nocardia farcinica,
dase E2 (MAE2) from Bradyrhizobium japonicum,
malonami-
[15]
amidase
AMI) from Rhodococcus globerulus, and cyclic imide hydro-
[b] Dr. Z. Assaf, Dr. D. Ribitsch, Prof. Dr. G. M. Guebitz
[16]
(
ACIB GmbH c/o
[17]
lase (CIH) from Pseudomonas putida were all cloned, overex-
pressed in E. coli, and purified, and their catalytic activity and
enantiospecificity were evaluated. In addition, computational
analysis of the resonance stabilization of the lactam amide
bond was used to rationalize the differences observed in
lactam reactivity.
Petersgasse 14, 8010 Graz (Austria)
[
c] Prof. Dr. G. M. Guebitz
Institute for Environmental Biotechnology
University of Natural Resources and Life Sciences
Konrad Lorenz Strasse 20, 3430 Tulln (Austria)
Supporting information (cloning and enzyme purification methods, com-
putational details, analytical methods, and synthesis of reference materi-
Five proteins were selected for initial lactamase activity
screening based on amino acid sequence or structure similarity
10.1002/cctc.201402077.
ꢁ
2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ChemCatChem 2014, 6, 2517 – 2521 2517